Home

Applications

APPLICATIONS OVERVIEW
DRUG DISCOVERY
ADME-Tox
Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Microsampling
Protein Crystallography
RNAi
Sample Management
CANCER RESEARCH
Personalized Medicine
Functional Screening / DSRT
RNAi
Sequencing
Single-cell Genomics
GENOMIC RESEARCH
Gene Expression
Genotyping
Microbiome
qPCR
Sequencing
Single-cell Genomics
Synthetic Biology

Products

LIQUID HANDLING
LIQUID HANDLERS OVERVIEW
Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler
AUTOMATION
AUTOMATION OVERVIEW
Access™ Laboratory Workstation
Tempo™ Automation Control Software
SOFTWARE APPLICATIONS
SOFTWARE OVERVIEW
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Compliance Manager
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat
CONSUMABLES
CONSUMABLES OVERVIEW
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime® Environmental Lid
Echo® Qualified Reservoir

Technology

Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Acoustic Mass Spectrometry
Direct Dilution

News / Events

Labcyte BLOG
Upcoming Events
Press Releases
Labcyte in the News
Labcyte Community

Resources

JALA Special Issue
Publications
Articles and Other Media
Application Notes
Posters
Webinars
Videos
Customer Profiles
Core Labs

Support

Brochures
Web Documentation*
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Service and Maintenance
Request Information

Company

About Us
Echo® Acoustic Technology
Leadership Team
Meet Labcyte
Careers
Contact and Location
Privacy Policy

TiEcon 2014 Announces Labcyte as a Winner of its TiE50 Award

The TiE50 awards program recognizes the 50 hottest technology start-ups globally

May 14, 2014

Sunnyvale, CA

Sunnyvale, Calif.─May 28, 2014─Labcyte Inc., the company that is revolutionizing life science research with the Echo® acoustic liquid handler, is pleased to announce that it has been selected as a Winner for the prestigious 2014 TiE50 Awards Program. Returning for the sixth year in a row, this year’s TiE50 was open to all technology companies worldwide.

“Receiving a TiE50 Award from a group of incredible entrepreneurs focused on driving advances in technology is a real honor,” said Mark Fischer-Colbrie, president and CEO of Labcyte Inc. “It is a reflection of Labcyte’s truly novel ability to use sound energy to transfer liquids with exquisite precision and control. Transferring liquids in increments of billionths of a liter with no pipettes solves a myriad of issues generated by traditional liquid handling techniques. As a result, it enables the discovery of new drugs, better diagnostic results and precision medicine. The Labcyte team has done an amazing job creating a system that can be used in hundreds of life science applications.”

“In the six short years since inception, the TiE 50 program has become a global brand that attracts thousands of companies worldwide for this recognition,” said Venktesh Shukla, president of TiE, Silicon Valley. “It is unique in terms of rigor of selection and the broad scope of companies that it reviews for this award and is one of TiE Silicon Valley’s most successful programs. It is also worth mentioning that this is the only awards recognition in technology to be held by a large global non-profit organization.”

To determine the winner, a panel of experts screened the companies and created a list of the “2014 TiE50 Top Startups.” This list was reviewed further by a screening committee of deep domain experts. About 100 of the best of the breed companies were selected to the elite TiE50 Finalist pool. Finally, this pool of TiE50 Finalists were judged by a panel of highly accomplished team made up of serial entrepreneurs, venture capitalists, angel investors, CEOs and well-rounded technology experts, to determine the winners. Companies were evaluated on three parameters: Business Model, IP Value and Leadership team.

“This year the TiE50 Awards Program screened more than 2800 companies from 27 countries. The finalist pool is represented by early through late stage companies. A star attraction of the conference is TiE50 Finalist and Winner presentations. Audiences are treated to great ideas and amazing technologies,” said Ram K. Reddy, the program chair.

The TiE50 track record since its inception in May 2009 shows that 94% of the winners and finalists have been funded, attracting Billions in investments. Many of these companies have been acquired, merged or gone public.

About Labcyte Inc.
Labcyte, a global biotechnology company headquartered in Sunnyvale, California, is revolutionizing liquid handling. Echo liquid handling systems use sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used worldwide throughout the pharmaceutical industry, as well as by biotechnology firms, contract research organizations, and academic institutions. Our customers work across a wide spectrum of scientific research, including drug discovery, genomics, proteomics, diagnostics, precision medicine, and imaging mass spectrometry. Labcyte has 53 US and multiple international patents issued, along with additional patent applications. For more information, visit www.labcyte.com.

About TiEcon:
TiEcon is the world’s largest conference for entrepreneurs and intrapreneurs with loyal participation from top technology companies, leading venture capital firms, and global service providers. TiEcon 2012 attracted 3,000+ attendees from across the world – including CEOs of established companies to first-time entrepreneurs creating new companies, to leading investment professionals and corporate executives. TiEcon was listed by Worth Magazine in their September 2011 issue to be among the 10 Best Conferences for Ideas and Entrepreneurship along with TED and the World Economic Forum. For more information on TiEcon, visit www.labcyte.com.

About TiE:
TiE is a global not-for-profit organization fostering entrepreneurship through mentoring, education, and networking. We consider entrepreneurship to be the single most powerful instrument to advance global prosperity. Our greatest strength is our network of over 60 chapters in 17 countries with a worldwide membership exceeding 14,000 that includes successful entrepreneurs, venture capitalists, corporate executives, and aspiring entrepreneurs. For more information on TiE, visit www.tie.org.




MAIN CONTACT
LABCYTE INC.
170 Rose Orchard Way
San Jose, California 95134
USA
Tel:
+1 408 747-2000
Toll-free:
+1 877 742-6548
Sales:
+1 877 742-6548, option 1
Fax:
+1 408 747-2010
Contact:
REQUEST INFO

PRESS CONTACT
Nicole Litchfield
Bioscribe, Inc.
Tel:
+1 415 793-6468
Email:
nicole@bioscribe.com
TOP